£107.85

Springer DJ-1/PARK7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases: 1037 (Advances in Experimental Medicine and Biology, 1037)

White

Price data last checked 93 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £20

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical
Generating forecast...
£107.85 £11.57 £32.57 £53.58 £74.59 £95.60 £116.60 23 May 2024 29 October 2024 06 April 2025 12 September 2025 19 February 2026

Price Distribution

Price distribution over 638 days • 4 price levels

Days at Price
Current Price
309 days 122 days 206 days 1 day · current 0 77 155 232 309 £20 £30 £40 £108 Days at Price

Price Analysis

Most common price: £20 (309 days, 48.4%)

Price range: £20 - £108

Price levels: 4 different prices over 638 days

Description

This book reviews the functions and roles of DJ-1 in various oxidative stress-related diseases and applications of DJ-1 and its binding compounds to the diseases. The  DJ-1 gene was first found to be a novel oncogene in 1997 and later, in 2003, also found to be a causative gene for a familial form of Parkinson’s disease (PD), park7. The  DJ-1 gene is therefore the first gene discovered that is known to cause cancer and neurodenegerative diseases, including PD. The research field has expanded as the research has developed. Thus this volume begins with a general introduction of  DJ-1, and explains the history and research development to understand the following chapters. Those chapters present the roles of  DJ-1 in various oxidative stress-related diseases such as neurodegenerative diseases, as well as cancer, diabetes, and fertility. Moreover, several chapters present evidence that DJ-1 is useful for therapeutic strategies against these diseases. The reader will discover that DJ-1 is a promising protein both for basic cell biology and for the mechanism and therapy for oxidative stress-related diseases.  From the Back Cover This book reviews the functions and roles of DJ-1 in various oxidative stress-related diseases and applications of DJ-1 and its binding compounds to the diseases. The DJ-1 gene was first found to be a novel oncogene in 1997 and later, in 2003, also found to be a causative gene for a familial form of Parkinson’s disease (PD), park7. The DJ-1 gene is therefore the first gene discovered that is known to cause cancer and neurodenegerative diseases, including PD. The research field has expanded as the research has developed. Thus this volume begins with a general introduction of DJ-1, and explains the history and research development to understand the following chapters. Those chapters present the roles of DJ-1 in various oxidative stress-related diseases such as neurodegenerative diseases, as well as cancer, diabetes, and fertility. Moreover, several chapters present evidence that DJ-1 is useful for therapeutic strategies against these diseases. The reader will discover that DJ-1 is a promising protein both for basic cell biology and for the mechanism and therapy for oxidative stress-related diseases.  About the Author Hiroyoshi Ariga Faculty of Pharmaceutical Sciences, Hokkaido University Sapporo, Japan Sanae M.M. Iguchi‐ArigaFaculty of Agriculture, Hokkaido University Sapporo,Japan

Product Specifications

Colour
White
Format
hardcover
Domain
Amazon UK
Release Date
04 December 2017
Listed Since
10 August 2017

Barcode

No barcode data available

Similar Products You Might Like

DJ-1/PARK7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases: 1037 (Advances in Experimental Medicine and Biology)
97% match

DJ-1/PARK7 Protein: Parkinson’s Disease, Cancer and Oxidative Stress-Induced Diseases: 1037 (Advances in Experimental Medicine and Biology)

Springer

£110.03 09 Mar 2026
Parkinson's Disease: Molecular and Therapeutic Insights From Model Systems
96% match

Parkinson's Disease: Molecular and Therapeutic Insights From Model Systems

Academic Press

£86.99 14 Apr 2026
Springer - Mitochondrial Mechanisms in Parkinson's Disease
96% match

Springer - Mitochondrial Mechanisms in Parkinson's Disease

Springer

£128.77 21 Apr 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
96% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Academic Press

£101.49 14 Apr 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
96% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£127.23 30 Jan 2026
Parkinson’s Disease―II: Aging and Neuroendocrine Relationships: 113 (Advances in Experimental Medicine and Biology, 113)
96% match

Parkinson’s Disease―II: Aging and Neuroendocrine Relationships: 113 (Advances in Experimental Medicine and Biology, 113)

Springer

£77.74 05 Mar 2026
Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease
96% match

Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

Springer

£130.25 06 Feb 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
96% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£80.09 05 Mar 2026
Gene Delivery and Therapy for Neurological Disorders: 98 (Neuromethods, 98)
95% match

Gene Delivery and Therapy for Neurological Disorders: 98 (Neuromethods, 98)

Humana

£83.65 18 Apr 2026
Neurotoxic Factors in Parkinson’s Disease and Related Disorders
95% match

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

Springer

£107.43 01 Mar 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
95% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Academic Press

£105.16 24 Feb 2026
Parkinson's Disease and Movement Disorders
95% match

Parkinson's Disease and Movement Disorders

Lippincott Williams and Wilkins

£171.27 23 Jan 2026
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2
95% match

Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2

Academic Press

£132.99 07 Feb 2026
Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)
95% match

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Elsevier

£220.00 12 Jan 2026
Handbook of Parkinson's Disease (Neurological Disease and Therapy)
95% match

Handbook of Parkinson's Disease (Neurological Disease and Therapy)

CRC Press

£95.00 13 Jan 2026
Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)
95% match

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

Elsevier

£180.00 13 Jan 2026
Molecular Mechanisms of Ataxia Telangiectasia (Medical Intelligence Unit (Unnumbered))
95% match

Molecular Mechanisms of Ataxia Telangiectasia (Medical Intelligence Unit (Unnumbered))

CRC Press

£130.00 07 Jan 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
95% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£99.59 14 Apr 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
95% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£192.44 12 Jan 2026
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)
95% match

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Springer

£110.89 11 Feb 2026
Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson’s Disease (Volume 2) (International Review of Movement Disorders, Volume 2)
95% match

Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson’s Disease (Volume 2) (International Review of Movement Disorders, Volume 2)

Academic Press

£170.39 10 Apr 2026
Disease-Modifying Targets in Neurodegenerative Disorders: Paving the Way for Disease-Modifying Therapies
95% match

Disease-Modifying Targets in Neurodegenerative Disorders: Paving the Way for Disease-Modifying Therapies

Academic Press

£62.29 12 Feb 2026
Inflammation in Parkinson's Disease: Scientific and Clinical Aspects
95% match

Inflammation in Parkinson's Disease: Scientific and Clinical Aspects

Springer

£86.31 18 Apr 2026
Parkinson's Disease: Genetics and Pathogenesis (Neurological Disease and Therapy)
95% match

Parkinson's Disease: Genetics and Pathogenesis (Neurological Disease and Therapy)

CRC Press

£143.26 14 Jan 2026